The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen.
Open Access
- 1 February 1992
- journal article
- case report
- Published by BMJ in Journal of Medical Genetics
- Vol. 29 (2) , 112-118
- https://doi.org/10.1136/jmg.29.2.112
Abstract
The features of three babies with perinatal lethal osteogenesis imperfecta (OI II) resulting from substitutions of glycine by valine in the triple helical domain of the alpha 1(I) chain of type I collagen were studied. The babies were heterozygous for this substitution at residue 1006 in case 1 (OI35), 973 in case 2 (OI59), and 256 in case 3 (OI7B). OI35 had the most severe clinical form, OI IIC, with premature rupture of membranes, severe antepartum haemorrhage, stillbirth, severe short limbed dwarfism, and extreme osteoporosis. OI59 was a better formed baby but was also born prematurely as a result of premature rupture of membranes and severe antepartum haemorrhage. She had the radiographic features of OI IIA. OI7B was born at term and also had the radiographic features of OI IIA. Pathological examination of the skeletons of OI35 and OI59 showed grossly deficient intramembranous and endochondral ossification. Trabecular bone was sparse in the long bones and vertebrae. The trabeculae contained a cartilage core and an overlying layer of woven bone or osteoid. The diaphyses lacked cortical bone. The periosteal fibroblasts of OI35 contained grossly distended rough endoplasmic reticulum consistent with the 53% reduction in collagen secretion by cultured dermal fibroblasts. The aorta, skin, and lungs were hypoplastic in OI35 and OI59. The findings in this study show that glycine substitutions by valine in Gly-X-Y triplets, from glycine 256 to glycine 1006, of the triple helical domain of alpha 1(I) chains produce the OI II phenotype. The phenotype was most severe in the baby with the most carboxy-terminal substitution.Keywords
This publication has 23 references indexed in Scilit:
- The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.Journal of Medical Genetics, 1990
- Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.Journal of Clinical Investigation, 1989
- A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.Journal of Clinical Investigation, 1989
- Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen geneNature, 1988
- Collagen defects in lethal perinatal osteogenesis imperfectaBiochemical Journal, 1986
- Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.Proceedings of the National Academy of Sciences, 1986
- Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type IINature, 1985
- Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneityAmerican Journal of Medical Genetics, 1984
- Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfectaBiochemical Journal, 1984
- Revised intrauterine growth curves for an Australian hospital populationJournal of Paediatrics and Child Health, 1983